• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Clinical features of advanced adenoid cystic carcinoma in the nasal cavity and paranasal sinuses: analysis of 21 cases].鼻腔及鼻窦晚期腺样囊性癌的临床特征:21例分析
Nan Fang Yi Ke Da Xue Xue Bao. 2017 Jun 20;37(6):847-852. doi: 10.3969/j.issn.1673-4254.2017.06.24.
2
Adenoid cystic carcinoma of the paranasal sinuses: retrospective series and review of the literature.鼻腔鼻窦腺样囊性癌:回顾性系列研究和文献复习。
Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Nov;130(5):257-62. doi: 10.1016/j.anorl.2012.09.010. Epub 2013 Jun 6.
3
[Management and prognosis of patients with squamous cell carcinomas of the nasal cavity and the paranasal sinuses].[鼻腔及鼻窦鳞状细胞癌患者的管理与预后]
Laryngorhinootologie. 2012 Oct;91(10):627-32. doi: 10.1055/s-0032-1321867. Epub 2012 Aug 28.
4
Reflections on the management of adenoid cystic carcinoma of the nasal cavity and paranasal sinuses.鼻腔及鼻窦腺样囊性癌的治疗思考
Otolaryngol Head Neck Surg. 1985 Jun;93(3):338-41. doi: 10.1177/019459988509300309.
5
[Malignomas of the nasal cavity and the paranasal sinuses: clinical characteristics, therapy and prognosis of different tumor types].[鼻腔及鼻窦恶性肿瘤:不同肿瘤类型的临床特征、治疗及预后]
Laryngorhinootologie. 2004 Jan;83(1):33-9. doi: 10.1055/s-2004-814108.
6
Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses - 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8).鼻腔、中耳和副鼻窦癌症-15 年按年龄、性别、种族、分期、分级、队列进入时间-时期、疾病持续时间和解剖学原发部位比较生存和死亡率分析:2000-2017 年诊断年的 13404 例病例的系统评价:(NCI SEER*Stat 8.3.8)。
J Insur Med. 2024 Jul 1;51(2):77-91. doi: 10.17849/insm-51-2-77-91.1.
7
[Clinical study on 88 cases of adenoid cystic carcinoma in nasal cavity and paranasal sinuses].88例鼻腔及鼻窦腺样囊性癌的临床研究
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Apr;44(4):311-4.
8
[Squamous epithelial carcinoma and undifferentiated carcinoma of the inner nose and paranasal sinuses].[内鼻及鼻窦鳞状上皮癌和未分化癌]
Strahlenther Onkol. 1989 Jun;165(6):468-73.
9
Non-intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses: an analysis of clinical characteristics and prognosis.鼻腔和鼻窦非肠型腺癌:临床特征和预后分析。
Eur Arch Otorhinolaryngol. 2024 Sep;281(9):4973-4982. doi: 10.1007/s00405-024-08715-9. Epub 2024 May 9.
10
Adenoid cystic carcinoma of the sinonasal tract: treatment results.鼻窦腺样囊性癌:治疗结果
Laryngoscope. 2006 Jun;116(6):982-6. doi: 10.1097/01.mlg.0000216900.03188.48.

引用本文的文献

1
[Comparison of prediction ability of two extended Cox models in nonlinear survival data analysis].[两种扩展Cox模型在非线性生存数据分析中的预测能力比较]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jan 20;43(1):76-84. doi: 10.12122/j.issn.1673-4254.2023.01.10.

本文引用的文献

1
Histopathological study of salivary gland tumors.唾液腺肿瘤的组织病理学研究。
J Oral Maxillofac Pathol. 2017 Jan-Apr;21(1):46-50. doi: 10.4103/0973-029X.203762.
2
Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.头颈部转移性腺样囊性癌生存模式的差异。
Head Neck. 2017 Mar;39(3):456-463. doi: 10.1002/hed.24613. Epub 2016 Oct 24.
3
Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?碳离子治疗(C12)对头颈部高级别恶性涎腺肿瘤(MSGTs)的疗效:非腺样囊性癌是否能从剂量递增中获益?
Radiat Oncol. 2016 Jul 7;11(1):90. doi: 10.1186/s13014-016-0657-z.
4
Endoscopic approach to the resection of adenoid cystic carcinoma of paranasal sinuses and nasal cavity: case report and own experience.鼻内镜下切除鼻窦和鼻腔腺样囊性癌:病例报告及个人经验
Eur J Med Res. 2015 Dec 12;20:97. doi: 10.1186/s40001-015-0189-2.
5
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling.腺样囊性癌:基于基因组分析的当前治疗方法及潜在治疗进展
Oncotarget. 2015 Nov 10;6(35):37117-34. doi: 10.18632/oncotarget.5076.
6
MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.头颈部腺样囊性癌中的MYB重排及临床病理特征
Laryngoscope. 2015 Sep;125(9):E292-9. doi: 10.1002/lary.25356. Epub 2015 May 11.
7
Clinicopathological review and survival characteristics of adenoid cystic carcinoma.腺样囊性癌的临床病理回顾及生存特征
Indian J Otolaryngol Head Neck Surg. 2015 Mar;67(Suppl 1):62-6. doi: 10.1007/s12070-014-0755-x. Epub 2014 Aug 5.
8
Adenoid cystic carcinoma of the nasal cavity and paranasal sinuses: a meta-analysis.鼻腔和鼻窦腺样囊性癌:一项荟萃分析
J Neurol Surg B Skull Base. 2013 Jun;74(3):118-25. doi: 10.1055/s-0033-1347358. Epub 2013 May 15.
9
Adenoid cystic carcinoma of the paranasal sinuses: retrospective series and review of the literature.鼻腔鼻窦腺样囊性癌:回顾性系列研究和文献复习。
Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Nov;130(5):257-62. doi: 10.1016/j.anorl.2012.09.010. Epub 2013 Jun 6.
10
125I brachytherapy alone for recurrent or locally advanced adenoid cystic carcinoma of the oral and maxillofacial region.125I 近距离放疗单独用于口腔颌面部复发性或局部晚期腺样囊性癌。
Strahlenther Onkol. 2013 Jun;189(6):502-7. doi: 10.1007/s00066-013-0324-3. Epub 2013 Apr 28.

鼻腔及鼻窦晚期腺样囊性癌的临床特征:21例分析

[Clinical features of advanced adenoid cystic carcinoma in the nasal cavity and paranasal sinuses: analysis of 21 cases].

作者信息

Wang Hui-Gang, Shen Cong-Xiang, Chen Fang, Li Guan-Xue, Wang Xiao-Qi, Wen Zhong

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China. E-mail:

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2017 Jun 20;37(6):847-852. doi: 10.3969/j.issn.1673-4254.2017.06.24.

DOI:10.3969/j.issn.1673-4254.2017.06.24
PMID:28669965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6744131/
Abstract

OBJECTIVE

To evaluate the clinical characteristics, treatment and prognosis of advanced adenoid cystic carcinoma (ACC) in the nasal cavity and paranasal sinuses.

METHODS

Twenty-one patients with advanced ACC in the nasal cavity and paranasal sinuses were treated in our department between February, 2007 and May, 2016. The clinical manifestations, T-stage, N-status, treatment, histological grade, recurrence and distant metastasis of the tumors were analyzed. Univariate survival analysis was performed with Kaplan-Meier method and Log-rank test, and the factors affecting the prognosis of the patients were explored using multivariate analysis with Cox proportional hazard model.

RESULTS

Among the 21 patients, 10 (47.6%) had ACC containing less than 30% of solid tumor tissues and their overall survival rates at 1, 3, and 5 years were 100%, 100% and 70%, respectively; in the 11 cases (52.4%) with solid tumor tissues no less than 30%, the overall survival rates at 1, 3, and 5 years were 70%, 40% and 10%, respectively, showing significant differences between the two groups (P=0.02). The Log-rank test and survival analysis using the covariate variable model curve indicated a significant impact of the pathological classification on the patients' prognosis. The patients in T3 stage had slightly better prognosis than those in T4 stage; tumors originating from the maxillary sinus had a slightly better prognosis than those from the sphenoid sinus. Surgery combined with radiotherapy resulted in better outcomes of the patients than surgery or radiotherapy alone. Multiariable Cox regression model analysis showed that the pathological classification (P=0.045) and the disease course (P=0.028) were closely related with the prognosis of the patients.

CONCLUSION

ACC in the nasal cavity and paranasal sinuses has a low incidence without specific symptoms. Its early diagnosis can be difficult, and most of the patients are in advanced stage upon diagnosis. We recommend comprehensive treatments combining surgery, postoperative radiotherapy and chemotherapy for these patients. The pathological classification, disease course, lesion site, clinical stage, treatment approache, compromise of the peripheral nerves, status at the edge of resection, and postoperative radiotherapy dose can all be factors affecting the prognosis of patients with advanced ACC.

摘要

目的

评估鼻腔及鼻窦晚期腺样囊性癌(ACC)的临床特征、治疗方法及预后。

方法

回顾性分析2007年2月至2016年5月在我科治疗的21例鼻腔及鼻窦晚期ACC患者的临床表现、T分期、N状态、治疗方法、组织学分级、肿瘤复发及远处转移情况。采用Kaplan-Meier法和Log-rank检验进行单因素生存分析,并用Cox比例风险模型进行多因素分析以探讨影响患者预后的因素。

结果

21例患者中,10例(47.6%)ACC实体瘤组织含量小于30%,其1年、3年和5年总生存率分别为100%、100%和70%;11例(52.4%)实体瘤组织含量不少于30%,其1年、3年和5年总生存率分别为70%、40%和10%,两组差异有统计学意义(P=0.02)。Log-rank检验及协变量变量模型曲线生存分析显示病理分类对患者预后有显著影响。T3期患者预后略好于T4期患者;起源于上颌窦的肿瘤预后略好于起源于蝶窦的肿瘤。手术联合放疗患者的治疗效果优于单纯手术或单纯放疗。多因素Cox回归模型分析显示,病理分类(P=0.045)和病程(P=0.028)与患者预后密切相关。

结论

鼻腔及鼻窦ACC发病率低,无特异性症状,早期诊断困难,多数患者确诊时已处于晚期。建议对这类患者采用手术、术后放疗及化疗相结合的综合治疗。病理分类、病程、病变部位、临床分期、治疗方法、周围神经受累情况、切缘状态及术后放疗剂量均可能是影响晚期ACC患者预后的因素。